Pharma Journalist 8916 posts 0 comments

SMi Group Reports: Co-chairs of the conference Michael Scherz and Naheed Mirza personal invitation to join the 21st Annual Pain Therapeutics Conference, taking place virtually this…
Read More...

Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

Valence Discovery an emerging leader in AI-enabled drug design, announced it has entered into a drug discovery agreement with Repare Therapeutics, a precision oncology company…
Read More...

Hoth Therapeutics, Inc. a biopharmaceutical company, today announced entering into a Research Agreement with the University of Cincinnati Research Institute ("UCRI") to perform critical…
Read More...

Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced preliminary results following vaccination of non-human primates with TNX-1800 (modified…
Read More...

M2GEN, a leading oncology-focused data and informatics company, announced a significant new five-year agreement with Merck, known as MSD outside the United States and Canada. Under the…
Read More...

Merck known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a New Drug Application…
Read More...

AstraZeneca has modified an existing agreement with the US Government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody (LAAB) combination which is in…
Read More...

Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 2/3 study, called the…
Read More...

WuXi Biologics announced that it has entered into an equity agreement with Pfizer China to acquire its state-of-the-art biologics manufacturing facilities as well as its labor force in…
Read More...